WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+13.42%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$10.8B
AUM Growth
+$1.65B
(+18%)
Cap. Flow
+$863M
Cap. Flow
% of AUM
7.98%
Top 10 Holdings %
Top 10 Hldgs %
14.33%
Holding
675
New
211
Increased
170
Reduced
126
Closed
150
Top Buys
| 1 |
ERF
Enerplus Corporation
ERF
|
$110M |
| 2 |
TE Connectivity
TEL
|
$84.6M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
$78.6M |
| 4 |
Honeywell
HON
|
$72.8M |
| 5 |
Palo Alto Networks
PANW
|
$71.1M |
Top Sells
| 1 |
AbbVie
ABBV
|
$116M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$113M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$88.1M |
| 4 |
Permian Resources
PR
|
$75M |
| 5 |
SPLK
Splunk Inc
SPLK
|
$70.1M |
Sector Composition
| 1 | Healthcare | 38.65% |
| 2 | Technology | 22.91% |
| 3 | Industrials | 9.85% |
| 4 | Energy | 8.37% |
| 5 | Consumer Discretionary | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
ArriVent BioPharma
AVBP
$819M
| $1.79M | 0.02% |
+100,000
| New | +$1.79M |
|
427
KalVista Pharmaceuticals
KALV
$796M
| $1.78M | 0.02% |
150,462
-196,401
| -57% | -$2.33M |
|
|
LBPH
428
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $1.75M | 0.02% |
+80,920
| New | +$1.75M |
|
429
Xoma
XOMA
$426M
| $1.73M | 0.02% |
72,106
+21,547
| +43% | +$518K |
|
430
Adicet Bio
ACET
$60M
| $1.73M | 0.02% |
+735,095
| New | +$1.73M |
|
431
Smith Douglas Homes
SDHC
$1.08B
| $1.7M | 0.02% |
+57,111
| New | +$1.7M |
|
432
Praxis Precision Medicines
PRAX
$986M
| $1.66M | 0.02% |
+27,263
| New | +$1.66M |
|
433
Sagimet Biosciences
SGMT
$231M
| $1.63M | 0.02% |
300,170
+1
| +0% | +$5 |
|
434
Kulicke & Soffa
KLIC
$1.99B
| $1.61M | 0.01% |
+32,099
| New | +$1.61M |
|
435
Corbus Pharmaceuticals
CRBP
$121M
| $1.61M | 0.01% |
+40,981
| New | +$1.61M |
|
436
Trex
TREX
$6.93B
| $1.59M | 0.01% |
15,976
-30,395
| -66% | -$3.03M |
|
437
Seres Therapeutics
MCRB
$169M
| $1.58M | 0.01% |
102,294
+37,780
| +59% | +$585K |
|
438
Fractyl Health
GUTS
$65.4M
| $1.56M | 0.01% |
+210,963
| New | +$1.56M |
|
439
Pliant Therapeutics
PLRX
$114M
| $1.49M | 0.01% |
100,143
-23,947
| -19% | -$357K |
|
440
Amylyx Pharmaceuticals
AMLX
$910M
| $1.49M | 0.01% |
523,772
+52,971
| +11% | +$150K |
|
441
Stoke Therapeutics
STOK
$1.13B
| $1.44M | 0.01% |
106,904
+50,000
| +88% | +$675K |
|
442
Stryker
SYK
$150B
| $1.35M | 0.01% |
3,759
-158,294
| -98% | -$56.6M |
|
443
Eledon Pharmaceuticals
ELDN
$162M
| $1.34M | 0.01% |
651,939
-37,401
| -5% | -$77K |
|
444
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $1.28M | 0.01% |
535,439
+35,439
| +7% | +$84.7K |
|
|
BLUE
445
DELISTED
bluebird bio
BLUE
| $1.25M | 0.01% |
48,758
+23,751
| +95% | +$608K |
|
446
Atara Biotherapeutics
ATRA
$90.7M
| $1.23M | 0.01% |
+70,992
| New | +$1.23M |
|
447
Caribou Biosciences
CRBU
$174M
| $1.22M | 0.01% |
237,277
-903,394
| -79% | -$4.64M |
|
|
OTLY
448
Oatly Group
OTLY
$524M
| $1.18M | 0.01% |
+52,137
| New | +$1.18M |
|
449
Graphic Packaging
GPK
$6.38B
| $1.15M | 0.01% |
+39,454
| New | +$1.15M |
|
450
Alector
ALEC
$305M
| $1.14M | 0.01% |
+190,000
| New | +$1.14M |
|